You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,915,154


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,915,154
Title: Method and apparatus for performing intra-operative angiography
Abstract:Method for assessing the patency of a patient's blood vessel, advantageously during or after treatment of that vessel by an invasive procedure, comprising administering a fluorescent dye to the patient; obtaining at least one angiographic image of the vessel portion; and evaluating the at least one angiographic image to assess the patency of the vessel portion. Other related methods are contemplated, including methods for assessing perfusion in selected body tissue, methods for evaluating the potential of vessels for use in creation of AV fistulas, methods for determining the diameter of a vessel, and methods for locating a vessel located below the surface of a tissue.
Inventor(s): Docherty; John C. (Winnipeg, CA), Hewko; Mark (Winnipeg, CA), Mangat; Gurpreet (Richmond Hill, CA), Flower; Robert W. (Hunt Valley, MD), Chari; Seshadri M. (Toronto, CA)
Assignee: National Research Council of Canada (Ontario, CA)
Application Number:09/744,034
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,915,154: A Detailed Analysis

Introduction

United States Patent 6,915,154, titled "Method and apparatus for performing intra-operative angiography," is a significant patent in the medical field, particularly in the area of surgical procedures. This patent, issued on July 5, 2005, describes innovative methods and apparatuses for conducting angiography during surgical operations. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background of the Patent

The patent was filed on October 26, 2000, and granted nearly five years later. It addresses a critical need in surgical procedures by providing a method and apparatus for intra-operative angiography, which is essential for real-time visualization of blood vessels during surgery[1].

Scope of the Patent

The scope of the patent encompasses several key aspects:

Method of Intra-operative Angiography

The method involves selecting a portion of body tissue to be analyzed, administering a fluorescent dye to the patient, and obtaining at least one image of the tissue using a fluorescence imaging system. This process allows surgeons to visualize blood vessels and other vascular structures in real-time, enhancing the accuracy and safety of surgical procedures[1].

Apparatus for Intra-operative Angiography

The apparatus includes a fluorescence imaging system, which may consist of a light source, a camera, and a display device. The system is designed to capture and display images of the fluorescent dye as it circulates through the blood vessels, providing immediate feedback to the surgeon[1].

Claims of the Patent

The patent includes multiple claims that define the scope of the invention:

Independent Claims

  • Claim 1 describes the method of intra-operative angiography, including the steps of selecting tissue, administering the fluorescent dye, and obtaining images.
  • Claim 10 outlines the apparatus for performing intra-operative angiography, detailing the components such as the light source, camera, and display device[1].

Dependent Claims

  • These claims further specify the details of the method and apparatus, such as the type of fluorescent dye used, the wavelength of the light source, and the type of imaging system employed[1].

Patent Landscape

Prior Art and Anticipation

The patent landscape for intra-operative angiography involves a review of prior art to ensure the novelty and non-obviousness of the invention. The patent office would have considered existing methods and apparatuses for angiography to determine whether the claimed invention was anticipated or obvious[2].

Related Patents and Applications

The Global Dossier service provided by the USPTO allows users to view the patent family for this application, including related applications filed at participating IP Offices. This helps in understanding the broader context and any potential overlaps or conflicts with other patents[4].

Legal and Regulatory Considerations

Claim Construction and Validity

The validity of the claims in this patent would be subject to legal scrutiny, including claim construction and the determination of whether the claims are definite and not overly broad. The Federal Circuit Court has established that claim construction is a question of law and receives de novo review on appeal[2].

Patent Scope and Quality

The scope of the patent is crucial in determining its quality and impact. Metrics such as independent claim length and count can be used to measure patent scope, with narrower claims often associated with a higher probability of grant and shorter examination processes[3].

Practical Implications

Surgical Applications

The method and apparatus described in this patent have significant practical implications for surgeons. Real-time visualization of blood vessels can improve surgical outcomes by reducing the risk of complications and enhancing precision[1].

Economic Impact

The economic impact of this patent includes potential reductions in healthcare costs by minimizing the need for additional procedures and improving patient recovery times. It also opens up new avenues for medical device manufacturers to develop and market related technologies.

Challenges and Controversies

Litigation and IPRs

Patents in the medical field are often subject to litigation and inter partes review (IPR) challenges. The validity and scope of the claims can be contested, leading to legal battles that can affect the patent's enforceability and the innovation landscape[2].

Ethical Considerations

The use of fluorescent dyes and advanced imaging systems raises ethical considerations, such as patient safety and the potential for adverse reactions. These factors must be carefully evaluated and addressed in the implementation of this technology.

Key Takeaways

  • Innovative Method and Apparatus: The patent introduces a novel method and apparatus for intra-operative angiography, enhancing surgical precision and safety.
  • Legal and Regulatory Compliance: The patent's validity and scope are subject to legal scrutiny, including claim construction and anticipation analyses.
  • Practical Implications: The technology has significant practical benefits for surgeons and patients, including improved surgical outcomes and potential economic savings.
  • Challenges and Controversies: The patent may face challenges through litigation and IPRs, and ethical considerations must be addressed.

FAQs

What is the primary purpose of United States Patent 6,915,154?

The primary purpose is to describe a method and apparatus for performing intra-operative angiography, enabling real-time visualization of blood vessels during surgery.

How does the method of intra-operative angiography work?

The method involves administering a fluorescent dye to the patient and using a fluorescence imaging system to capture and display images of the dye as it circulates through the blood vessels.

What are the key components of the apparatus described in the patent?

The apparatus includes a light source, a camera, and a display device, all part of a fluorescence imaging system.

What legal considerations are important for this patent?

Claim construction, validity, and potential challenges through litigation and IPRs are crucial legal considerations.

How does this patent impact surgical practices?

It enhances surgical precision and safety by providing real-time visualization of blood vessels, potentially reducing complications and improving patient recovery times.

Sources

  1. US6915154B1 - Method and apparatus for performing intra-operative angiography - Google Patents
  2. VASCULAR SOLUTIONS LLC v. MEDTRONIC, INC. - CAFC
  3. Patent Claims and Patent Scope - SSRN
  4. Search for patents - USPTO - USPTO

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,915,154

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,915,154

PCT Information
PCT FiledAugust 11, 2000PCT Application Number:PCT/US00/22088
PCT Publication Date:April 05, 2001PCT Publication Number: WO01/22870

International Family Members for US Patent 6,915,154

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 375749 ⤷  Subscribe
Austria 506005 ⤷  Subscribe
Australia 6767500 ⤷  Subscribe
Australia 782257 ⤷  Subscribe
Brazil 0014289 ⤷  Subscribe
Canada 2339214 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.